idarubicin

RxCUI 5650 ingredient

Contraindicated with · 20

Diagnoses7

Hyperbilirubinemia Liver Failure Hepatic Insufficiency Renal Insufficiency Pregnancy Reproduction Drug Hypersensitivity

Condition families13

Liver Diseases Kidney Diseases Reproductive Physiological Phenomena Urologic Diseases Male Urogenital Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Digestive System Diseases Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 25

Diagnoses8

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Myeloid, Acute Leukemia, Lymphoid Leukemia, Myeloid Leukemia Chronic Disease Disease Attributes

Condition families17

Myeloproliferative Disorders Bone Marrow Diseases Breast Neoplasms Breast Diseases Lymphatic Diseases Immunoproliferative Disorders Lymphoproliferative Disorders Neoplasms by Histologic Type Neoplasms by Site Hematologic Diseases Hemic and Lymphatic Diseases Neoplasms Skin Diseases Skin and Connective Tissue Diseases Pathologic Processes Immune System Diseases Pathological Conditions, Signs and Symptoms

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.